{"id":"https://openalex.org/W4362526239","doi":"https://doi.org/10.1158/1535-7163.22500112","title":"Supplementary Methods from Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition","display_name":"Supplementary Methods from Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362526239","doi":"https://doi.org/10.1158/1535-7163.22500112"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22500112","doi":"https://doi.org/10.1158/1535-7163.22500112","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500112","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Phosphoproteomics_of_MAPK_Inhibition_in_BRAF-Mutated_Cells_and_a_Role_for_the_Lethal_Synergism_of_Dual_BRAF_and_CK2_Inhibition/22500112/1/files/39959389.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Phosphoproteomics_of_MAPK_Inhibition_in_BRAF-Mutated_Cells_and_a_Role_for_the_Lethal_Synergism_of_Dual_BRAF_and_CK2_Inhibition/22500112/1/files/39959389.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Robert Parker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Parker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066999906","display_name":"Roderick John Clifton-Bligh","orcid":"https://orcid.org/0000-0002-1545-0368","observed_orcids":["https://orcid.org/0000-0002-1545-0368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roderick Clifton-Bligh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069735960","display_name":"Mark P. Molloy","orcid":"https://orcid.org/0000-0003-4679-5868","observed_orcids":["https://orcid.org/0000-0003-4679-5868"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark P. Molloy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.9279999732971191},{"id":"https://openalex.org/keywords/mapk-inhibition","display_name":"MAPK inhibition","score":0.9810000061988831},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/ck2-inhibition","display_name":"CK2 inhibition","score":0.843999981880188},{"id":"https://openalex.org/keywords/dual-kinase-inhibition","display_name":"dual kinase inhibition","score":0.7360000014305115},{"id":"https://openalex.org/keywords/synergistic-lethality","display_name":"synergistic lethality","score":0.7990000247955322}],"concepts":[{"id":"https://openalex.org/C6675166","wikidata":"https://www.wikidata.org/wiki/Q7187538","display_name":"Phosphoproteomics","level":5,"score":0.8770213723182678},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5819693207740784},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.5286942720413208},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5061594843864441},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.445840060710907},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.43014830350875854},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3535197377204895},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2923867106437683},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.2239704132080078},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1973080337047577},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.16782018542289734},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.13811343908309937},{"id":"https://openalex.org/C87325107","wikidata":"https://www.wikidata.org/wiki/Q7251493","display_name":"Protein phosphorylation","level":4,"score":0.0},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22500112","doi":"https://doi.org/10.1158/1535-7163.22500112","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500112","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Phosphoproteomics_of_MAPK_Inhibition_in_BRAF-Mutated_Cells_and_a_Role_for_the_Lethal_Synergism_of_Dual_BRAF_and_CK2_Inhibition/22500112/1/files/39959389.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22500112","doi":"https://doi.org/10.1158/1535-7163.22500112","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22500112","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Phosphoproteomics_of_MAPK_Inhibition_in_BRAF-Mutated_Cells_and_a_Role_for_the_Lethal_Synergism_of_Dual_BRAF_and_CK2_Inhibition/22500112/1/files/39959389.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362526239.pdf","grobid_xml":"https://content.openalex.org/works/W4362526239.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2126713930","https://openalex.org/W4362493013","https://openalex.org/W1538562831","https://openalex.org/W4362614346","https://openalex.org/W3033174922","https://openalex.org/W1968014303","https://openalex.org/W6964727404","https://openalex.org/W4361953392","https://openalex.org/W4362537337","https://openalex.org/W2602578690"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-06T00:00:00"}